- Investor's Business Daily•8 hours ago
Dow leader Merck swiped share from rival Bristol-Myers as Roche remained flat, according to a health tracker.
- Zacks•15 hours ago
Roche Holding (RHHBY) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
- Zacks•6 days ago
Prothena (PRTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RO.SW : Summary for ROCHE I - Yahoo Finance
Roche Holding AG (RO.SW)
Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
|Day's Range||248.50 - 251.50|
|52 Week Range||221.80 - 265.50|
|PE Ratio (TTM)||22.50|
|Dividend & Yield||8.23 (3.23%)|
|1y Target Est||N/A|